Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-22 | Sep-30-22 | Sep-05-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Sep-05-21 |
| | 10-Q | 10-K | 8-K | 10-Q | 10-Q | 10-Q | 10-K | 8-K |
| Revenues: |
| Royalties | | 7.3 | | 7.8 | 8.4 | | 7.6 | |
| Product Sales | | 8.0 | | 6.7 | 6.4 | | 6.3 | |
| License Fees | | 2.3 | | 1.0 | 1.5 | | 1.2 | |
| Other | | 2.0 | | 2.0 | 2.2 | | 2.2 | |
| Medical Device revenues | 19.0 | 19.5 | | 17.5 | 18.5 | 16.9 | 17.4 | |
| Revenue growth [+] | 12.5% | 12.1% | | 4.6% | -33.9% | 4.4% | 1.3% | |
| Royalties | | -5.2% | | 0.2% | 11.8% | | -7.3% | |
| Product Sales | | 26.1% | | 22.7% | 19.1% | | 17.6% | |
| License Fees | | 83.9% | | -1.9% | -88.2% | | -24.1% | |
| EBITDA | -5.3 | -4.2 | | -5.3 | -3.5 | -1.6 | 1.4 | |
| EBITDA margin | -27.8% | -21.5% | | -30.2% | -18.9% | -9.5% | 8.2% | |
| Depreciation and amortization | 2.0 | 2.0 | | 2.0 | 2.1 | 2.2 | 2.2 | |
| EBIT | -7.2 | -6.2 | | -7.3 | -5.6 | -3.8 | -0.8 | |
| EBIT margin | -38.0% | -31.9% | | -41.7% | -30.4% | -22.4% | -4.6% | |
| |
| Revenue Mix | 76.3% | 75.0% | | 70.5% | 70.7% | 73.5% | 72.6% | |
| EBIT Mix | | | | | | | | |
|